Sallam M, Khalil R
Microorganisms. 2024; 12(6).
PMID: 38930417
PMC: 11205832.
DOI: 10.3390/microorganisms12061035.
Mertowska P, Smolak K, Mertowski S, Grywalska E
Int J Mol Sci. 2023; 24(12).
PMID: 37373262
PMC: 10298684.
DOI: 10.3390/ijms241210115.
Cheng X, Wei Y, Jiang X, Wang C, Liu M, Yan J
Pharmaceuticals (Basel). 2022; 15(11).
PMID: 36355531
PMC: 9693017.
DOI: 10.3390/ph15111359.
Karamichali E, Foka P, Papadopoulou G, Loukaki-Gkountara D, Andresaki K, Koskinas I
Int J Mol Sci. 2022; 23(18).
PMID: 36142773
PMC: 9505460.
DOI: 10.3390/ijms231810862.
Kayesh M, Kohara M, Tsukiyama-Kohara K
Int J Mol Sci. 2022; 23(10).
PMID: 35628287
PMC: 9141274.
DOI: 10.3390/ijms23105475.
A Review of Hepatitis B Virus and Hepatitis C Virus Immunopathogenesis.
Saraceni C, Birk J
J Clin Transl Hepatol. 2021; 9(3):409-418.
PMID: 34221927
PMC: 8237136.
DOI: 10.14218/JCTH.2020.00095.
Identification of Interleukin1β as an Amplifier of Interferon alpha-induced Antiviral Responses.
Robichon K, Maiwald T, Schilling M, Schneider A, Willemsen J, Salopiata F
PLoS Pathog. 2020; 16(10):e1008461.
PMID: 33002089
PMC: 7553310.
DOI: 10.1371/journal.ppat.1008461.
Impact of IFN-Free and IFN-Based Treatment on Blood Myeloid Dendritic Cell, Monocyte, Slan-DC, and Activated T Lymphocyte Dynamics during HCV Infection.
Vita S, Zuccala P, Savinelli S, Mascia C, Rossi R, Schiavone F
J Immunol Res. 2020; 2020:2781350.
PMID: 32258171
PMC: 7102477.
DOI: 10.1155/2020/2781350.
and Are Proviral Host Factors for Hepatitis C Virus.
Hu P, Wilhelm J, Gerresheim G, Shalamova L, Niepmann M
Viruses. 2019; 11(6).
PMID: 31200545
PMC: 6631246.
DOI: 10.3390/v11060549.
Cellular Gene Expression during Hepatitis C Virus Replication as Revealed by Ribosome Profiling.
Gerresheim G, Bathke J, Michel A, Andreev D, Shalamova L, Rossbach O
Int J Mol Sci. 2019; 20(6).
PMID: 30875926
PMC: 6470931.
DOI: 10.3390/ijms20061321.
Immune Cell Trafficking to the Liver.
Chaudhry S, Emond J, Griesemer A
Transplantation. 2019; 103(7):1323-1337.
PMID: 30817405
PMC: 7044802.
DOI: 10.1097/TP.0000000000002690.
Molecular Mechanisms Involved in HCC Recurrence after Direct-Acting Antiviral Therapy.
Villani R, Vendemiale G, Serviddio G
Int J Mol Sci. 2018; 20(1).
PMID: 30583555
PMC: 6337751.
DOI: 10.3390/ijms20010049.
Interferon at the cellular, individual, and population level in hepatitis C virus infection: Its role in the interferon-free treatment era.
Raja R, Baral S, Dixit N
Immunol Rev. 2018; 285(1):55-71.
PMID: 30129199
PMC: 6614028.
DOI: 10.1111/imr.12689.
Modelling how responsiveness to interferon improves interferon-free treatment of hepatitis C virus infection.
Venugopal V, Padmanabhan P, Raja R, Dixit N
PLoS Comput Biol. 2018; 14(7):e1006335.
PMID: 30001324
PMC: 6057683.
DOI: 10.1371/journal.pcbi.1006335.
Model of the adaptive immune response system against HCV infection reveals potential immunomodulatory agents for combination therapy.
Obaid A, Naz A, Ikram A, Awan F, Raza A, Ahmad J
Sci Rep. 2018; 8(1):8874.
PMID: 29891859
PMC: 5995896.
DOI: 10.1038/s41598-018-27163-0.
Macrophage-Derived Extracellular Vesicles Induce Long-Lasting Immunity Against Hepatitis C Virus Which Is Blunted by Polyunsaturated Fatty Acids.
Cai C, Koch B, Morikawa K, Suda G, Sakamoto N, Rueschenbaum S
Front Immunol. 2018; 9:723.
PMID: 29706960
PMC: 5906748.
DOI: 10.3389/fimmu.2018.00723.
The relationship between human leukocyte antigen-DP/DQ gene polymorphisms and the outcomes of HCV infection in a Chinese population.
Huang P, Fan H, Tian T, Liao P, Li J, Yu R
Virol J. 2017; 14(1):235.
PMID: 29212520
PMC: 5719872.
DOI: 10.1186/s12985-017-0901-7.
Oxidative Stress and Immune Responses During Hepatitis C Virus Infection in Tupaia belangeri.
Kayesh M, Ezzikouri S, Sanada T, Chi H, Hayashi Y, Rebbani K
Sci Rep. 2017; 7(1):9848.
PMID: 28852124
PMC: 5575003.
DOI: 10.1038/s41598-017-10329-7.
Asunaprevir Evokes Hepatocytes Innate Immunity to Restrict the Replication of Hepatitis C and Dengue Virus.
Tsai W, Cheng J, Shu C, Lai K, Chan H, Wu C
Front Microbiol. 2017; 8:668.
PMID: 28473813
PMC: 5397474.
DOI: 10.3389/fmicb.2017.00668.
HCV coinfection contributes to HIV pathogenesis by increasing immune exhaustion in CD8 T-cells.
Rallon N, Garcia M, Garcia-Samaniego J, Rodriguez N, Cabello A, Restrepo C
PLoS One. 2017; 12(3):e0173943.
PMID: 28323897
PMC: 5360268.
DOI: 10.1371/journal.pone.0173943.